Needless Antibiotics Often Doled Out to Asthmatic Kids

Pediatric asthma patients are nearly twice as likely to be prescribed an unnecessary antibiotic, compared with other pediatric patients, during an office or emergency department visit, recent studies revealed.

Needless Antibiotics Often Doled Out to Asthmatic Kids

Tylenol Use Linked to Asthma, Other Allergies in Teens

Teens from around the world who regularly take acetaminophen, best known as Tylenol, were more than twice as likely to have asthma as teens who never take the over-the-counter pain and fever reducer, new research finds.

Tylenol Use Linked to Asthma, Other Allergies in Teens

Asthma drug ruling 'nonsensical'

Asthma drug ruling 'nonsensical'

The NHS watchdog has been accused of being "nonsensical" for denying young children with severe asthma access to a drug.

Drug for severly asthmatic children 'available in Scotland but not England'

Drug for severly asthmatic children 'available in Scotland but not England'

A drug which can radically reduce the number of attacks suffered by severely asthmatic children will not be available on the NHS in England after the Government’s drug rationing body ruled it was too expensive.

Denver boy, 9, died after state-benefits error denied him meds

A Montbello mother says her 9-year-old son's death from severe asthma could have been prevented had Denver Human Services resolved problems with his Medicaid pharmacy benefits.

More >> Denver boy, 9, died after state-benefits error denied him meds

FDA investigating link between asthma drug and heart attack, stroke risk

An ongoing clinical trial of the asthma drug Xolair suggests that patients taking the medication may have an increased risk of blood clots, heart failure, stroke, cardiac arrhythmias and heart enlargement when compared to patients not treated with the asthma drug, the Food and Drug Administration said Thursday. The agency announced it was assessing the significance of the preliminary findings to determine if further regulatory actions are necessary to protect patients.

Omalizumab, marketed as Xolair, is approved as a treatment for adults and children older than 12 who suffer from moderate to severe asthma complicated by seasonal allergies.

More >> FDA investigating link between asthma drug and heart attack, stroke risk